Coeptis Therapeutics Holdings, Inc. Reports Voting Results from Annual Meeting

Coeptis Therapeutics Holdings, Inc. recently conducted its Annual Meeting of Stockholders on December 18, 2024. The meeting saw an active participation from shareholders who voted on various proposals as detailed in the definitive proxy statement filed with the Securities and Exchange Commission (SEC) on November 14, 2024. Out of the 41,118,593 shares of the Company’s […]

Leave a Reply

Your email address will not be published.

Previous post Editorial: Biden has Christmas present for Death Row, coal for victims’ families
Next post Kopin (NASDAQ:KOPN) Cut to “Sell” at StockNews.com